(Q36647710)

English

Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand

scientific article published on 25 March 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

1 reference

based on heuristic

inferred from title

latent tuberculosis

1 reference

based on heuristic

inferred from title

0 references

author name string

Saiyud Moolphate

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Saranath Lawpoolsri

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Petchawan Pungrassami

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Natpatou Sanguanwongse

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Norio Yamada

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jaranit Kaewkungwal

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

25 March 2013

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Global Journal of Health Science

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

60-70

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Global evidence directing regional preventive strategies in Southeast Asia for fighting TB/HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

The effect of tuberculosis on mortality in HIV positive people: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Isoniazid preventive therapy and risk for resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Effectiveness and efficiency of guideline dissemination and implementation strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

30 September 2017

Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

28 June 2018

Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4776827

20 September 2018

Recommendations of the Interim Policy on Collaborative TB/HIV activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/23777722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey of isoniazid preventive therapy in South Africa, 2011

1 reference

https://pubmed.ncbi.nlm.nih.gov/23777722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis preventive therapy in HIV-infected individuals. A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23777722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5539/GJHS.V5N4P60

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

release_2kdj7ftqbrbvbdtztqlzju26se

1 reference

https://api.fatcat.wiki/v0/release/2kdj7ftqbrbvbdtztqlzju26se

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36647710&oldid=1843605896"